跳转至内容
Merck
CN

142387

2,4,6-三甲基吡啶

99%, liquid, ReagentPlus®

别名:

2,4,6-三甲基氮杂苯, 对称-三甲基吡啶

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C8H11N
化学文摘社编号:
分子量:
121.18
NACRES:
NA.21
PubChem Substance ID:
UNSPSC Code:
12352100
EC Number:
203-613-3
MDL number:
Beilstein/REAXYS Number:
107283
Assay:
99%
Form:
liquid
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

2,4,6-三甲基吡啶, ReagentPlus®, 99%

InChI key

BWZVCCNYKMEVEX-UHFFFAOYSA-N

InChI

1S/C8H11N/c1-6-4-7(2)9-8(3)5-6/h4-5H,1-3H3

SMILES string

Cc1cc(C)nc(C)c1

product line

ReagentPlus®

assay

99%

form

liquid

Quality Level

bp

171-172 °C (lit.)

mp

−43 °C (lit.)

density

0.917 g/mL at 25 °C (lit.)

正在寻找类似产品? 访问 产品对比指南

General description

2,4,6-三甲基吡啶是一种吡啶衍生物。它具有7.4的pK。该产物可与环戊烷溶液中的三氟碘甲烷反应生成1:1的络合物。可通过NMR(核磁共振)光谱对该络合物进行研究。通过向其中加入四氧化锇溶液来制备可力丁缓冲的四氧化锇溶液。这些溶液已被用作电子显微镜研究的固定剂。
2,4,6-三甲基吡啶可用高锰酸钾氧化形成2,4,6-吡啶三羧酸。
受阻的基底。

Application

2,4,6-三甲基吡啶(可力丁,s-可力丁,2,4,6-可力丁)已被用于制备带有低分子量N-酰基的N-酰基氨基香豆素的文库。
可用于通过无水碘化锂裂解位阻酯的有用溶剂。
用作电子显微镜的组织固定剂。

Legal Information

ReagentPlus is a registered trademark of Merck KGaA, Darmstadt, Germany

pictograms

FlameSkull and crossbones

signalword

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 4 Oral - Aquatic Chronic 3 - Eye Irrit. 2 - Flam. Liq. 3 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

存储类别

3 - Flammable liquids

wgk

WGK 3

flash_point_f

131.0 °F - closed cup

flash_point_c

55 °C - closed cup

ppe

Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter

法规信息

危险化学品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Synthesis, structure, photoluminescence and magnetic properties of new 3-D lanthanide-pyridine-2, 4, 6-tricarboxylate frameworks
Li C-J, et al.
CrystEngComm, 10(11), 1645-1652 (2008)
Andrew W Patterson et al.
Nature protocols, 2(2), 424-433 (2007-04-05)
Substrate activity screening (SAS) is a fragment-based method for the rapid development of novel substrates and their conversion into non-peptidic inhibitors of Cys and Ser proteases. The method consists of three steps: (i) a library of N-acyl aminocoumarins with diverse
Leszek Pazderski et al.
Magnetic resonance in chemistry : MRC, 48(6), 417-426 (2010-05-18)
(1)H, (13)C and (15)N NMR studies of gold(III), palladium(II) and platinum(II) chloride complexes with dimethylpyridines (lutidines: 2,3-lutidine, 2,3lut; 2,4-lutidine, 2,4lut; 3,5-lutidine, 3,5lut; 2,6-lutidine, 2,6lut) and 2,4,6-trimethylpyridine (2,4,6-collidine, 2,4,6col) having general formulae [AuLCl(3)], trans-[PdL(2)Cl(2)] and trans-/cis-[PtL(2)Cl(2)] were performed and the respective
Janet E Del Bene et al.
The journal of physical chemistry. A, 110(3), 1128-1133 (2006-01-20)
Ab initio EOM-CCSD calculations have been performed on 3:1 FH:NH3 complexes at their own optimized MP2/6-31+G(d,p) geometries and at the optimized geometries in the hydrogen-bonding regions of corresponding 3:1 FH:collidine complexes. The isolated gas-phase equilibrium 3:1 FH:NH3 complex has an
J L Tomsig et al.
Histochemistry, 89(3), 301-306 (1988-01-01)
In previous work of our laboratory it was demonstrated that collidine (2,4,6-trimethylpyridine) abolishes the core osmiophilia and chromaffin reaction from rat pinal gland and vas deferens nerves. This abolition was apparent when tissues were briefly incubated in collidine or when

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持